Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20499)

• Formulation Name: Sulindac 150 mg tablet
• Company: Actavis Pharma; Bryant Ranch Prepack; Physicians Total Care

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Sulindac	(DM2QHZU)	Acute myelogenous leukaemia	2A41	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant